Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleNeuropsychiatric Imaging

Effects of Psilocybin on Mouse Brain Microstructure

Paloma C. Frautschi, Ajay P. Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks and John-Paul J. Yu
American Journal of Neuroradiology June 2025, 46 (6) 1216-1222; DOI: https://doi.org/10.3174/ajnr.A8634
Paloma C. Frautschi
aFrom the Department of Radiology (P.C.F., A.P.S., J.-P.J.Y.), University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajay P. Singh
aFrom the Department of Radiology (P.C.F., A.P.S., J.-P.J.Y.), University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
bGraduate Program in Cellular and Molecular Biology (A.P.S., J.-P.J.Y.), University of Wisconsin-Madison, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas A. Stowe
cNeuroscience Training Program, Wisconsin Institutes for Medical Research (N.A.S., Z.Z., M.I.B., J.-P.J.Y.), University of Wisconsin-Madison, Madison, Wisconsin
dDepartment of Psychiatry (N.A.S. J.-P.J.Y.), University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean M. Grady
eDepartment of Anesthesiology (S.M.G. M.I.B.), School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sean M. Grady
Zarmeen Zahid
cNeuroscience Training Program, Wisconsin Institutes for Medical Research (N.A.S., Z.Z., M.I.B., J.-P.J.Y.), University of Wisconsin-Madison, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew I. Banks
cNeuroscience Training Program, Wisconsin Institutes for Medical Research (N.A.S., Z.Z., M.I.B., J.-P.J.Y.), University of Wisconsin-Madison, Madison, Wisconsin
eDepartment of Anesthesiology (S.M.G. M.I.B.), School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John-Paul J. Yu
aFrom the Department of Radiology (P.C.F., A.P.S., J.-P.J.Y.), University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
bGraduate Program in Cellular and Molecular Biology (A.P.S., J.-P.J.Y.), University of Wisconsin-Madison, Madison, Wisconsin
cNeuroscience Training Program, Wisconsin Institutes for Medical Research (N.A.S., Z.Z., M.I.B., J.-P.J.Y.), University of Wisconsin-Madison, Madison, Wisconsin
dDepartment of Psychiatry (N.A.S. J.-P.J.Y.), University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Khan AJ,
    2. Bradley E,
    3. O’Donovan A, et al
    . Psilocybin for trauma-related disorders. Curr Top Behav Neurosci 2022;56:319–32 doi:10.1007/7854_2022_366 pmid:35711024
    CrossRefPubMed
  2. 2.↵
    1. Moreno FA,
    2. Wiegand CB,
    3. Taitano EK, et al
    . Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 2006;67:1735–40
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. Bogenschutz MP,
    2. Forcehimes AA,
    3. Pommy JA, et al
    . Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29:289–99 doi:10.1177/0269881114565144
    CrossRefPubMed
  4. 4.↵
    1. Carhart-Harris RL,
    2. Bolstridge M,
    3. Rucker J, et al
    . Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3:619–27 doi:10.1016/S2215-0366(16)30065-7 pmid:27210031
    CrossRefPubMed
  5. 5.↵
    1. Davis AK,
    2. Barrett FS,
    3. May DG, et al
    . Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2021;78:481–89 doi:10.1001/jamapsychiatry.2020.3285 pmid:33146667
    CrossRefPubMed
  6. 6.↵
    1. Raison CL,
    2. Sanacora G,
    3. Woolley J, et al
    . Single-dose psilocybin treatment for major depressive disorder. JAMA 2023;330:843 doi:10.1001/jama.2023.14530
    CrossRefPubMed
  7. 7.↵
    1. van Amsterdam J,
    2. van den Brink W
    . The therapeutic potential of psilocybin: a systematic review. Expert Opin Drug Saf 2022;21:833–40 doi:10.1080/14740338.2022.2047929 pmid:35225143
    CrossRefPubMed
  8. 8.↵
    1. Goel DB,
    2. Zilate S
    . Potential therapeutic effects of psilocybin: a systematic review. Cureus 2022;14:e30214 doi:10.7759/cureus.30214 pmid:36381758
    CrossRefPubMed
  9. 9.↵
    1. Goodwin GM,
    2. Aaronson ST,
    3. Alvarez O, et al
    . Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med 2022;387:1637–48 doi:10.1056/NEJMoa2206443
    CrossRefPubMed
  10. 10.↵
    1. Shao LX,
    2. Liao C,
    3. Gregg I, et al
    . Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 2021;109:2535–44 doi:10.1016/j.neuron.2021.06.008 pmid:34228959
    CrossRefPubMed
  11. 11.↵
    1. de la Fuente Revenga M,
    2. Zhu B,
    3. Guevara CA, et al
    . Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice. Cell Rep 2021;37:109836 doi:10.1016/j.celrep.2021.109836 pmid:34686347
    CrossRefPubMed
  12. 12.↵
    1. Davoudian PA,
    2. Shao LX,
    3. Kwan AC
    . Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin. ACS Chem Neurosci 2023;14:468–80 doi:10.1021/acschemneuro.2c00637 pmid:36630309
    CrossRefPubMed
  13. 13.↵
    1. Martin DA,
    2. Nichols CD
    . Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain. EBioMedicine 2016;11:262–77 doi:10.1016/j.ebiom.2016.08.049 pmid:27649637
    CrossRefPubMed
  14. 14.↵
    1. Hesselgrave N,
    2. Troppoli TA,
    3. Wulff AB, et al
    . Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc Natl Acad Sci U S A 2021;118:e2022489118 doi:10.1073/pnas.2022489118
    Abstract/FREE Full Text
  15. 15.↵
    1. Preller KH,
    2. Duerler P,
    3. Burt JB, et al
    . Psilocybin induces time-dependent changes in global functional connectivity. Biol Psychiatry 2020;88:197–207 doi:10.1016/j.biopsych.2019.12.027 pmid:32111343
    CrossRefPubMed
  16. 16.↵
    1. Grimm O,
    2. Kraehenmann R,
    3. Preller KH, et al
    . Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. Eur Neuropsychopharmacol 2018;28:691–700 doi:10.1016/j.euroneuro.2018.03.016
    CrossRefPubMed
  17. 17.↵
    1. Carhart-Harris RL,
    2. Leech R,
    3. Hellyer PJ, et al
    . The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 2014;8:20 doi:10.3389/fnhum.2014.00020 pmid:24550805
    CrossRefPubMed
  18. 18.↵
    1. Barrett FS,
    2. Doss MK,
    3. Sepeda ND, et al
    . Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep 2020;10:2214 doi:10.1038/s41598-020-59282-y pmid:32042038
    CrossRefPubMed
  19. 19.↵
    1. McCulloch DEW,
    2. Madsen MK,
    3. Stenbæk DS, et al
    . Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals. J Psychopharmacol 2022;36:74–84 doi:10.1177/02698811211026454
    CrossRefPubMed
  20. 20.↵
    1. Daws RE,
    2. Timmermann C,
    3. Giribaldi B, et al
    . Increased global integration in the brain after psilocybin therapy for depression. Nat Med 2022;28:844–51 doi:10.1038/s41591-022-01744-z pmid:35411074
    CrossRefPubMed
  21. 21.↵
    1. Tagliazucchi E,
    2. Carhart-Harris R,
    3. Leech R, et al
    . Enhanced repertoire of brain dynamical states during the psychedelic experience. Hum Brain Mapp 2014;35:5442–56 doi:10.1002/hbm.22562 pmid:24989126
    CrossRefPubMedWeb of Science
  22. 22.↵
    1. Frautschi PC,
    2. Singh AP,
    3. Stowe NA, et al
    . Multimodal neuroimaging of the effect of serotonergic psychedelics on the brain. AJNR Am J Neuroradiol 2024;45:833–40 doi:10.3174/ajnr.A8118 pmid:38360790
    Abstract/FREE Full Text
  23. 23.↵
    1. Yi SY,
    2. Barnett BR,
    3. Yu JPJ
    . Preclinical neuroimaging of gene-environment interactions in psychiatric disease. Br J Radiol 2019;92:20180885
    CrossRefPubMed
  24. 24.↵
    1. Zhang H,
    2. Schneider T,
    3. Wheeler-Kingshott CA, et al
    . NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 2012;61:1000–16 doi:10.1016/j.neuroimage.2012.03.072 pmid:22484410
    CrossRefPubMed
  25. 25.↵
    1. Faillace LA,
    2. Vourlekis A,
    3. Szara S
    . Clinical evaluation of some hallucinogenic tryptamine derivatives. J Nerv Ment Dis 1967;145:306–13
    CrossRefPubMedWeb of Science
  26. 26.↵
    1. Blair JB,
    2. Kurrasch-Orbaugh D,
    3. Marona-Lewicka D, et al
    . Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. J Med Chem 2000;43:4701–10 doi:10.1021/jm000339w pmid:11101361
    CrossRefPubMedWeb of Science
  27. 27.↵
    1. Ly C,
    2. Greb AC,
    3. Cameron LP, et al
    . psychedelics promote structural and functional neural plasticity. Cell Rep 2018;23:3170–82 doi:10.1016/j.celrep.2018.05.022 pmid:29898390
    CrossRefPubMed
  28. 28.↵
    1. Gattuso JJ,
    2. Wilson C,
    3. Hannan AJ, et al
    . Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: a systematic review. J Neurochem 2024;168:1687–720 doi:10.1111/jnc.16017 pmid:38019032
    CrossRefPubMed
  29. 29.↵
    1. Holmes HE,
    2. Powell NM,
    3. Ma D, et al
    . Comparison of in vivo and ex vivo MRI for the detection of structural abnormalities in a mouse model of tauopathy. Front Neuroinform 2017;11:20 doi:10.3389/fninf.2017.00020 pmid:28408879
    CrossRefPubMed
  30. 30.↵
    1. Lerch JP,
    2. Gazdzinski L,
    3. Germann J, et al
    . Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse. Front Neuroinform 2012;6:6 doi:10.3389/fninf.2012.00006 pmid:22470335
    CrossRefPubMed
  31. 31.↵
    1. Paxinos G,
    2. Franklin KBJ
    . The Mouse Brain in Stereotaxic Coordinates: Hard Cover Edition. 2nd ed. Academic Press; 2001.
  32. 32.↵
    1. Zhang Y,
    2. Zhang Y,
    3. Ai H, et al
    . Microstructural deficits of the thalamus in major depressive disorder. Brain Commun 2022;4:fcac236 doi:10.1093/braincomms/fcac236 pmid:36196087
    CrossRefPubMed
  33. 33.↵
    1. Kumar P,
    2. Goer F,
    3. Murray L, et al
    . Impaired reward prediction error encoding and striatal-midbrain connectivity in depression. Neuropsychopharmacology 2018;43:1581–88 doi:10.1038/s41386-018-0032-x pmid:29540863
    CrossRefPubMed
  34. 34.↵
    1. Nestler EJ,
    2. Barrot M,
    3. DiLeone RJ, et al
    . Neurobiology of depression. Neuron 2002;34:13–25 doi:10.1016/s0896-6273(02)00653-0 pmid:11931738
    CrossRefPubMedWeb of Science
  35. 35.↵
    1. Andrade C
    . Multiple testing and protection against a type 1 (false positive) error using the Bonferroni and Hochberg corrections. Indian J Psychol Med 2019;41:99–100 doi:10.4103/IJPSYM.IJPSYM_499_18 pmid:30783320
    CrossRefPubMed
  36. 36.↵
    1. Nutt D,
    2. Erritzoe D,
    3. Carhart-Harris R
    . Psychedelic psychiatry’s brave new world. Cell 2020;181:24–28 doi:10.1016/j.cell.2020.03.020 pmid:32243793
    CrossRefPubMed
  37. 37.↵
    1. Carhart-Harris RL,
    2. Friston KJ
    . REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 2019;71:316–44 doi:10.1124/pr.118.017160 pmid:31221820
    Abstract/FREE Full Text
  38. 38.↵
    1. Barrett FS,
    2. Krimmel SR,
    3. Griffiths R, et al
    . Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. Neuroimage 2020;218:116980 doi:10.1016/j.neuroimage.2020.116980 pmid:32454209
    CrossRefPubMed
  39. 39.↵
    1. Carhart-Harris RL,
    2. Erritzoe D,
    3. Williams T, et al
    . Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A 2012;109:2138–43 doi:10.1073/pnas.1119598109 pmid:22308440
    Abstract/FREE Full Text
  40. 40.↵
    1. Gaddis A,
    2. Lidstone DE,
    3. Nebel MB, et al
    . Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity. Neuroimage 2022;260:119434 doi:10.1016/j.neuroimage.2022.119434 pmid:35792293
    CrossRefPubMed
  41. 41.↵
    1. Siegel JS,
    2. Subramanian S,
    3. Perry D, et al
    . Psilocybin desynchronizes the human brain. Nature 2024;632:131–38 doi:10.1038/s41586-024-07624-5 pmid:39020167
    CrossRefPubMed
  42. 42.↵
    1. Van De Werd HJJM,
    2. Uylings HBM
    . Comparison of (stereotactic) parcellations in mouse prefrontal cortex. Brain Struct Funct 2014;219:433–59 doi:10.1007/s00429-013-0630-7 pmid:24072162
    CrossRefPubMed
  43. 43.↵
    1. Pearson J,
    2. Chiou R,
    3. Rogers S, et al
    . Sensory dynamics of visual hallucinations in the normal population. Elife 2016;5:e17072 doi:10.7554/eLife.17072
    CrossRefPubMed
  44. 44.↵
    1. Bhome R,
    2. Thomas GEC,
    3. Zarkali A, et al
    . Structural and functional imaging correlates of visual hallucinations in Parkinson’s disease. Curr Neurol Neurosci Rep 2023;23:287–99 doi:10.1007/s11910-023-01267-1 pmid:37126201
    CrossRefPubMed
  45. 45.↵
    1. Copa D,
    2. Erritzoe D,
    3. Giribaldi B, et al
    . Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. J Affect Disord 2024;353:60–69 doi:10.1016/j.jad.2024.02.089 pmid:38423367
    CrossRefPubMed
  46. 46.↵
    1. Gattuso JJ,
    2. Perkins D,
    3. Ruffell S, et al
    . Default mode network modulation by psychedelics: a systematic review. Int J Neuropsychopharmacol 2023;26:155–88 doi:10.1093/ijnp/pyac074
    CrossRef
  47. 47.↵
    1. Lyons T,
    2. Spriggs M,
    3. Kerkelä L, et al
    . Human brain changes after first psilocybin use. bioRxiv doi:10.1101/2024.10.11.617955. Accessed .
    Abstract/FREE Full Text
  48. 48.↵
    1. Jaster AM,
    2. Younkin J,
    3. Cuddy T, et al
    . Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice. Neurosci Lett 2022;788:136836 doi:10.1016/j.neulet.2022.136836 pmid:35963476
    CrossRefPubMed
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 46 (6)
American Journal of Neuroradiology
Vol. 46, Issue 6
1 Jun 2025
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Psilocybin on Mouse Brain Microstructure
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Paloma C. Frautschi, Ajay P. Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John-Paul J. Yu
Effects of Psilocybin on Mouse Brain Microstructure
American Journal of Neuroradiology Jun 2025, 46 (6) 1216-1222; DOI: 10.3174/ajnr.A8634

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Effect of psilocybin on mouse brain microstructure
Paloma C. Frautschi, Ajay P. Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John-Paul J. Yu
American Journal of Neuroradiology Jun 2025, 46 (6) 1216-1222; DOI: 10.3174/ajnr.A8634
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Gad Deposition and Sensory & Cognitive Functions
  • Diffusivity & Cognitive Deficit in Marijuana Users
Show more Neuropsychiatric Imaging

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire